isoproterenol has been researched along with atglistatin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuperlovic-Culf, M; D'Souza, K; Kienesberger, PC; Roy, PP; Touaibia, M | 1 |
| Breinbauer, R; Dyck, JRB; Ferdaoussi, M; Kershaw, EE; Maayah, ZH; Migglautsch, AK; Soni, S; Srnic, N; Takahara, S | 1 |
2 other study(ies) available for isoproterenol and atglistatin
| Article | Year |
|---|---|
New Atglistatin closely related analogues: Synthesis and structure-activity relationship towards adipose triglyceride lipase inhibition.
Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Chemistry Techniques, Synthetic; Enzyme Inhibitors; Isoproterenol; Lipase; Lipolysis; Mice; Phenylurea Compounds; Structure-Activity Relationship | 2016 |
Inhibition of ATGL in adipose tissue ameliorates isoproterenol-induced cardiac remodeling by reducing adipose tissue inflammation.
Topics: Adipose Tissue, White; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Fibroblasts; Galectin 3; Heart Diseases; Inflammation Mediators; Isoproterenol; Lipase; Lipolysis; Male; Mice, Inbred C57BL; Myocardium; Paracrine Communication; Phenylurea Compounds; Signal Transduction; Ventricular Remodeling | 2021 |